Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis

Erica Ramstad*, Ole Jakob Storebø, Trine Gerner, Helle B. Krogh, Mathilde Holmskov, Frederik L. Magnusson, Carlos R. Moreira-Maia, Maria Skoog, Camilla Groth, Donna Gillies, Morris Zwi, Richard Kirubakaran, Christian Gluud, Erik Simonsen

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftArtikelForskningpeer review


Background:There is little evidence in the literature on the association between methylphenidate treatment and psychotic symptoms in children and adolescents with attention-deficit/hyperactivity disorder (ADHD).Objective:We examine the occurrence of psychotic symptoms during methylphenidate treatment of children and adolescents with ADHD. The data arise from our two Cochrane systematic reviews on methylphenidate,
Sider (fra-til)52-71
Antal sider20
TidsskriftScandinavian Journal of Child and Adolescent Psychiatry and Psychology
Udgave nummer1
StatusUdgivet - 2018


  • Publiceret originalartikel
  • attention-deficit/hyperactivity disorder
  • deficit hyperactivity disorder
  • Review
  • methylphenidate
  • open-label
  • adverse events
  • design characteristics
  • mood dysregulation
  • oros methylphenidate
  • psychotic symptoms
  • release methylphenidate
  • transdermal system
  • visual hallucinations